DK1037648T3 - Anvendelse af erythropoietin og jernpræparater til fremstilling af farmaceutiske kombinationspræparater til behandling af rheumatiske lidelser - Google Patents

Anvendelse af erythropoietin og jernpræparater til fremstilling af farmaceutiske kombinationspræparater til behandling af rheumatiske lidelser

Info

Publication number
DK1037648T3
DK1037648T3 DK98943842T DK98943842T DK1037648T3 DK 1037648 T3 DK1037648 T3 DK 1037648T3 DK 98943842 T DK98943842 T DK 98943842T DK 98943842 T DK98943842 T DK 98943842T DK 1037648 T3 DK1037648 T3 DK 1037648T3
Authority
DK
Denmark
Prior art keywords
preparation
preparations
treatment
erythropoietin
iron
Prior art date
Application number
DK98943842T
Other languages
Danish (da)
English (en)
Inventor
Paul Lehmann
Joachim Peter Kaltwasser
Original Assignee
Roche Diagnostics Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Roche Diagnostics Gmbh filed Critical Roche Diagnostics Gmbh
Application granted granted Critical
Publication of DK1037648T3 publication Critical patent/DK1037648T3/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18Growth factors; Growth regulators
    • A61K38/1816Erythropoietin [EPO]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/02Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Rheumatology (AREA)
  • Zoology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Pain & Pain Management (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DK98943842T 1997-08-08 1998-08-05 Anvendelse af erythropoietin og jernpræparater til fremstilling af farmaceutiske kombinationspræparater til behandling af rheumatiske lidelser DK1037648T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19734293A DE19734293A1 (de) 1997-08-08 1997-08-08 Verwendung von pharmazeutischen Kombinationspräparaten enthaltend Erythropoietin und Eisenpräparate zur Behandlung von rheumatischen Erkrankungen
PCT/EP1998/004864 WO1999007401A2 (de) 1997-08-08 1998-08-05 Verwendung von erythropoietin und eisenpräparaten zur herstellung von pharmazeutischen kombinationspräparaten zur behandlung von rheumatischen erkrankungen

Publications (1)

Publication Number Publication Date
DK1037648T3 true DK1037648T3 (da) 2004-08-02

Family

ID=7838328

Family Applications (1)

Application Number Title Priority Date Filing Date
DK98943842T DK1037648T3 (da) 1997-08-08 1998-08-05 Anvendelse af erythropoietin og jernpræparater til fremstilling af farmaceutiske kombinationspræparater til behandling af rheumatiske lidelser

Country Status (15)

Country Link
US (1) US6372715B1 (ja)
EP (1) EP1037648B1 (ja)
JP (3) JP2001513510A (ja)
KR (1) KR100478573B1 (ja)
CN (1) CN1170589C (ja)
AT (1) ATE263571T1 (ja)
AU (1) AU738027B2 (ja)
BR (1) BR9811086A (ja)
CA (1) CA2297959C (ja)
DE (2) DE19734293A1 (ja)
DK (1) DK1037648T3 (ja)
ES (1) ES2218851T3 (ja)
PT (1) PT1037648E (ja)
TR (1) TR200000369T2 (ja)
WO (1) WO1999007401A2 (ja)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU226204B1 (en) * 1997-03-18 2008-06-30 Roche Diagnostics Gmbh Use of erythropoietin and iron preparations for producing of combined pharmaceutical preparations
DE19734293A1 (de) * 1997-08-08 1999-02-11 Boehringer Mannheim Gmbh Verwendung von pharmazeutischen Kombinationspräparaten enthaltend Erythropoietin und Eisenpräparate zur Behandlung von rheumatischen Erkrankungen
MEP90708A (en) * 2000-05-15 2011-12-20 New pharmaceutical composition
US6929954B2 (en) 2000-11-02 2005-08-16 Chromaceutical Advanced Technologies, Inc. Method for producing purified hematinic iron-saccharidic complex and product produced
BR0115100A (pt) 2000-11-02 2003-09-30 Chromaceutical Advanced Tech Métodos para monitorar um produto de complexo ferro-sacarìdico, para purificar uma composição, e para produzir uma composição hematìnica, complexo ferro-sacarìdico, e, complexo hematìnico reconstituìdo
ES2361824T3 (es) 2000-12-20 2011-06-22 F. Hoffmann-La Roche Ag Conjugados de eritropoyetina (epo) con polietilenglicol (peg).
EP1909106B1 (en) 2001-09-14 2013-01-02 F. Hoffmann-La Roche AG Differential diagnosis of disorders of iron metabolism by means of four parameters and recommendations for the treatment of these disorders of iron metabolism
US7459435B2 (en) * 2002-08-29 2008-12-02 Hoffmann-La Roche Inc. Treatment of disturbances of iron distribution
US7459436B2 (en) * 2002-11-22 2008-12-02 Hoffmann-La Roche Inc. Treatment of disturbances of iron distribution
US7964568B2 (en) * 2003-05-30 2011-06-21 Chromaceutical Advanced Technologies, Inc. Synthesis of high molecular weight iron-saccharidic complexes
KR20070107106A (ko) * 2005-02-09 2007-11-06 비포르 (인터내셔날) 아게 철(ⅲ) 착화합물의 용도
NZ627177A (en) 2005-05-16 2016-02-26 Abbvie Biotechnology Ltd Use of tnf inhibitor for treatment of erosive polyarthritis
EP1790356A1 (de) * 2005-11-24 2007-05-30 Vifor (International) Ag Präparat, umfassend Eisen(III)-Komplexverbindungen und redoxaktive Substanz(en)
US9605064B2 (en) 2006-04-10 2017-03-28 Abbvie Biotechnology Ltd Methods and compositions for treatment of skin disorders
WO2007120656A2 (en) * 2006-04-10 2007-10-25 Abbott Biotechnology Ltd. Uses and compositions for treatment of rheumatoid arthritis
US20080131374A1 (en) * 2006-04-19 2008-06-05 Medich John R Uses and compositions for treatment of rheumatoid arthritis
KR101304081B1 (ko) 2006-08-04 2013-09-05 프로롱 파마슈티컬스, 엘엘씨 수식된 에리스로포이에틴
US20080132465A1 (en) * 2006-12-05 2008-06-05 Vincent Windisch Apparatus and method for isolating iron components from serum
AR067537A1 (es) * 2007-07-17 2009-10-14 Hoffmann La Roche Purificacion de polipeptidos pegilados
AR067536A1 (es) 2007-07-17 2009-10-14 Hoffmann La Roche Metodo para obtener una eritropoyetina mono-pegilada en una forma sustancialmente homogenea
WO2009118662A2 (en) * 2008-03-24 2009-10-01 Abbott Biotechnology Ltd. Methods and compositions for treating bone loss
US8202830B2 (en) 2009-01-30 2012-06-19 Ecolab Usa Inc. Development of an aluminum hydroxydicarboxylate builder
AU2010209328B2 (en) * 2009-01-30 2015-07-02 Ecolab Inc. Development of an aluminum hydroxycarboxylate builder
US8536106B2 (en) 2010-04-14 2013-09-17 Ecolab Usa Inc. Ferric hydroxycarboxylate as a builder
JP6085401B2 (ja) * 2014-07-25 2017-02-22 原 和弘 薬剤投与情報提供装置及び薬剤投与情報提供のためのコンピュータプログラム
EP3380487B1 (en) 2015-11-23 2020-09-02 Bristol-Myers Squibb Company Additive systems for use in protein pegylation

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ194947A (en) 1979-09-18 1983-06-14 C Holland Composition containing calcium and ferrous ions for treatment of rheumatoid arthritis
US4732889A (en) * 1985-02-06 1988-03-22 Chugai Seiyaku Kabushiki Kaisha Pharmaceutical composition for the treatment of the anemia of rheumatoid arthritis
ES2206521T3 (es) 1994-11-03 2004-05-16 Roche Diagnostics Gmbh Utilizacion de la eritropoyetina en el tratamiento de artritis reumatoide.
DE19535571A1 (de) * 1995-09-14 1997-03-20 Boehringer Mannheim Gmbh Pharmazeutische Kombinationspräparate und deren Verwendung zur Behandlung von Hämodialysepatienten
DE19734293A1 (de) * 1997-08-08 1999-02-11 Boehringer Mannheim Gmbh Verwendung von pharmazeutischen Kombinationspräparaten enthaltend Erythropoietin und Eisenpräparate zur Behandlung von rheumatischen Erkrankungen

Also Published As

Publication number Publication date
WO1999007401A2 (de) 1999-02-18
US6372715B1 (en) 2002-04-16
AU738027B2 (en) 2001-09-06
EP1037648A2 (de) 2000-09-27
TR200000369T2 (tr) 2000-09-21
CA2297959A1 (en) 1999-02-18
CA2297959C (en) 2011-11-29
BR9811086A (pt) 2000-08-29
JP2012012410A (ja) 2012-01-19
JP2008133290A (ja) 2008-06-12
DE19734293A1 (de) 1999-02-11
JP2001513510A (ja) 2001-09-04
CN1268058A (zh) 2000-09-27
KR100478573B1 (ko) 2005-03-28
ES2218851T3 (es) 2004-11-16
CN1170589C (zh) 2004-10-13
DE59811158D1 (de) 2004-05-13
KR20010022738A (ko) 2001-03-26
AU9159098A (en) 1999-03-01
PT1037648E (pt) 2004-08-31
EP1037648B1 (de) 2004-04-07
ATE263571T1 (de) 2004-04-15
WO1999007401A3 (de) 1999-04-29

Similar Documents

Publication Publication Date Title
DK1037648T3 (da) Anvendelse af erythropoietin og jernpræparater til fremstilling af farmaceutiske kombinationspræparater til behandling af rheumatiske lidelser
HRP20020088B1 (en) Levodopa/carbidopa/entacapone pharmaceutical preparation
TR200002207T1 (tr) Slekoksib bileşikleri.
NO20101190L (no) Anvendelse av buprenorfin i fremstillingen av et medikament
IS5500A (is) Lyfjablöndur til öftrunar og meðferðar mýlildi ogtengdum sjúkdómum
SE9704869D0 (sv) New pharmaceutical formulaton II
AR032293A1 (es) Estuche farmaceutico
IS7006A (is) Tvívetnis 3-piperidínóprópíófenon og lyf sem innihalda téð efnasambönd
HK1068606A1 (en) Novel aminobenzoephenones
PT998287E (pt) Utilizacao de levobupivacaina
GR1002847B (el) Χρηση της μισοπροστολης ή/και της μισοπροστολης οξυ για την παρασκευη φαρμακευτικου προιοντος για τη θεραπευτικη αντιμετωπιση των δυσλειτουργιων της στυσεως
HUP0104647A2 (hu) Hatóanyagként tilidin-mezilátot tartalmazó, szabályozott hatóanyag-leadású gyógyszerkészítmény
HUP9700806A2 (hu) Tianeptin-nátriumsó nyújtott felszabadulását biztosító, szájon át beadható mátrix tabletta és eljárás előállítására
ES2191449T3 (es) Derivados de ciclopentabenzofurano y su uso.
SE8901003L (sv) Snabbloesliga preparat
NO943288L (no) Anvendelse av pentoksyfyllin ved fremstilling av farmasöytiske preparater til behandling av granulomatöse og fibroserende lungesykdommer
IS1910B (is) Notkun á fankínóni til meðhöndlunar á Alzheimers-sjúkdómi
BG108452A (en) Tablet comprising cetirizine and pseudoephedrine
MXPA02011533A (es) Nuevas formulaciones de alfa-2,4-disulfofenil-n-terc-butilnitrona.
HUP9901659A2 (hu) Flupirtin alkalmazása a hematopoetikus sejtrendszer károsodásával kapcsolatos megbetegedések megelőzésére és gyógyítására alkalmas gyógyszerkészítmény előállítására
HUP0200145A2 (hu) Tianeptin alkalmazása neurodegeneratív betegségek kezelésére alkalmas gyógyszerkészítmények előállítására
TR199700963T1 (xx) Kardiyovask�ler hastal�klar�n tedavisi i�in aminotetralin t�revi.
IT8026233A0 (it) Derivato della n-acetil-cisteina ad attivita' terapeutica, procedimento per la sua preparazione e relative composizioni farmaceutiche.
PT1231908E (pt) Composicao farmaceutica compreendendo um composto dador de no e sua utilizacao em terapia
DK0927031T3 (da) Farmaceutisk sammensætning indeholdende nimesulid til oral admnistration